New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence
Author:
Publisher
Wiley
Subject
Ophthalmology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0420.2006.00711.x/fullpdf
Reference81 articles.
1. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy;Adamis;Am J Ophthalmol,1994
2. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene and zinc for age-related macular degeneration and vision loss. AREDS Report 8;Age-related Eye Disease Study Research Group;Arch Ophthalmol,2001
3. Efficacy of transpupillary thermotherapy (TTT) in the treatment of occult subfoveal choroidal neovascularization in age-related macular degeneration;Ahuja;Semin Ophthalmol,2001
4. Transpupillary thermotherapy of occult CNV with no or minimally classic CNV in age-related macular degeneration;Algvere;Semin Ophthalmol,2001
5. The role of oxidative stress in the pathogenesis of age-related macular degeneration;Beatty;Surv Ophthalmol,2000
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ranibizumab therapy for predominantly hemorrhagic neovascular age-related macular degeneration;Northern Clinics of Istanbul;2021
2. Epimacular brachytherapy for wet AMD: current perspectives;Clinical Ophthalmology;2014-08
3. Clinical course of patients with exudative-haemorrhagic age-related macular degeneration treated with ranibizumab. Eye2Eye study;Archivos de la Sociedad Española de Oftalmología (English Edition);2013-06
4. Evolución clínica de pacientes con degeneración macular asociada a la edad de tipo exudativo-hemorrágico tratados con ranibizumab. Estudio Eye2Eye;Archivos de la Sociedad Española de Oftalmología;2013-06
5. Topical nepafenac for treatment of exudative age-related macular degeneration;Acta Ophthalmologica;2010-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3